ID   PC-B-142CA
AC   CVCL_B7I1
DR   cancercelllines; CVCL_B7I1
DR   Wikidata; Q112930252
RX   PubMed=34651665;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: ER-negative, PR-negative, ERBB2-positive.
CC   Doubling time: 45 +- 3 hours (PubMed=34651665).
CC   Karyotypic information: 38 chromosomes with a chr X monosomy (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871Leu (c.2612C>T); ClinVar=VCV000041812; Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser425Cys (c.1274C>G); Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.7806-14T>C; ClinVar=VCV000126158; Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Glu839Lys (c.2515G>A); ClinVar=VCV000013862; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln224Ter (c.670C>T); Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Thr (c.695T>C); ClinVar=VCV000141224; Zygosity=Homozygous (PubMed=34651665).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=34651665
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 31.2
ST   D2S1338: 16,24
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=34651665; DOI=10.3892/or.2021.8205; PMCID=PMC8548790;
RA   Thongchot S., Jamjuntra P., Prasopsiri J., Thuwajit P., Sawasdee N.,
RA   Poungvarin N., Warnnissorn M., Sa-nguanraksa D., O-Charoenrat P.,
RA   Yenchitsomanus P.-T., Thuwajit C.;
RT   "Establishment and characterization of novel highly aggressive
RT   HER2-positive and triple-negative breast cancer cell lines.";
RL   Oncol. Rep. 46:254.1-254.13(2021).
//